Skip to content | Change text size

VCP4031

Pharmaceutics III ( 6 points, SCA Band 2, 0.125 EFTSL)

Undergraduate
(PHA)

Leader: Dr Margaret Doherty

Offered:
Parkville First semester 2005 (Day)

Synopsis: Biopharmaceutics - peroral, buccal, rectal, percutaneous, ocular, nasal, vaginal, parenteral and protein delivery. Therapeutic drug monitoring - prediction of dosage. Use of population paratmeters. Bayesian and probability methods. Applied pharmaceutics - the application of pharmaceutics including the knowledge of the physico-chemical properties of the drug, formulation strategies, biopharmaceutics and pharmacokinetics to understanding the dosage form and the implications for its use in practice.

Objectives: Students will develop an: - Understanding of the different routes of drug delivery and the factors that influence the delivery of drugs to the body; and principles of therapeutic drug monitoring. - Understanding of the sources and consequences of nonlinear pharmacokinetics in drug therapy. - Understanding of the pharmacokinetics of drug interactions. - Ability in applying the knowledge of pharmaceutics to understanding the science of contemporary dosage forms and their use in the practice of pharmacy.

Assessment: End-of-semester examination: 70% (2 hours) + Workshop assignments: 30%

Prerequisites: VCP3031, VCP 3032 and all preceding units of previous year's study. All 3rd year B.Pharm units

Corequisites: There are no special co-requisites for this unit